Disc Medicine, Inc. Share Price

Disc Medicine, Inc. Share Price

NASDAQ: IRON | Mid Cap
$80.78
-$2.14 (-2.58%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Disc Medicine, Inc. Stock Performance

Open
$82.75
Prev. Close
$82.92
Circuit Range
N/A
Day Range
$79.15 - $82.86
Year Range
$40.12 - $97.08
Volume
37,414
Average Traded
$80.75

Disc Medicine, Inc. Share Price Today

As of 31 October 2026, Disc Medicine, Inc.'s share price is $80.78. The stock opened at $82.75, compared to its previous close of $82.92. During today's trading session, Disc Medicine, Inc.'s share price traded between $79.15 and $82.86, with an average price of $81.00. Over the past 52 weeks, the stock has recorded a high of $97.08 and a low of $40.12. In terms of performance, Disc Medicine, Inc.'s share price has risen by 22.61% over the last six months and is down 6.37% on a year-on-year basis.

Disc Medicine, Inc. Share Price Chart

Line chart of the Disc Medicine, Inc. price trend over the selected period. The price fell overall, ranging from 79.44 to 82.86, ending at 80.76.
$79.15$82.86
L
Show Current Price
H

Disc Medicine, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.85B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.54
Revenue (TTM)
$0.00
Return On Equity (TTM)
-38.17%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
4.48%

Disc Medicine, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$62.32-$60.53-$63.50-$59.53
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A2.87%-4.91%6.25%

Disc Medicine, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$0.18-$76.43-$109.36-$212.18
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-42361.11%-43.09%-94.02%

About Disc Medicine, Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Disc Medicine, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$65.44
$80.81
+23.06%
Sep 2026
$78.10
$65.67
-20.48%
Aug 2026
$75.68
$82.58
+7.23%
Jul 2026
$73.06
$77.01
+5.42%
Jun 2026
$69.01
$73.05
+5.02%
May 2026
$66.05
$69.56
+5.57%
Apr 2026
$63.76
$65.89
+2.98%
Mar 2026
$64.84
$63.98
-4.04%
Feb 2026
$78.14
$66.68
-13.66%
Jan 2026
$79.25
$77.23
-2.78%
Dec 2025
$93.00
$79.44
-14.90%
Nov 2025
$87.39
$93.35
+8.19%

IRON Share Price FAQs